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Summary
Objective: We evaluated three methodologies e a calcium sodium alginate compound (CSAC), polyacrylate beads (PABs), and Whatman
paper recovery (WPR) e for the ability to recover synovial ﬂuid (SF) from mouse knees in a manner that facilitated biochemical marker
analysis.
Methods: Pilot testing of each of these recovery vehicles was conducted using small volumes of waste human SF. CSAC emerged as the
method of choice, and was used to recover and quantify SF from the knees of C57BL/6 mice (n¼ 12), six of which were given left knee
articular fractures. SF concentrations of cartilage oligomeric matrix protein (COMP) were measured by enzyme-linked immunosorbent assay.
Results: The mean concentration ratio [(COMPleft knee)/(COMPright knee)] was higher in the mice subjected to articular fracture when compared
to the non-fracture mice (P¼ 0.026). The mean total COMP ratio (taking into account the quantitative recovery of SF) best discriminated
between fracture and non-fracture knees (P¼ 0.004).
Conclusions: Our results provide the ﬁrst direct evidence of accelerated joint tissue turnover in a mouse model responding to acute joint injury.
These data strongly suggest that mouse SF recovery is feasible and that biomarker analysis of collected SF samples can augment traditional
histological analyses in mouse models of arthritis.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is a degenerative disease estimated to
affect 70e90% of the population aged 75 years and older1.
Although radiographic grading is the current standard for
the diagnosis and tracking of OA2, a variety of biological
markers, or ‘‘biomarkers’’, in the serum, urine, or synovial
ﬂuid (SF) have also shown correlations with OA severity3e7.
Recently, the sparse availability of diseased human tissue
and the inherent difﬁculty of ﬁnding a relatively homogenous
sample group have prompted continuing research in animal
models of OA to provide repeatable and cost-effective models
of disease progression8e13. In particular, mouse models of
OA, based on transgenic and knock-in/knock-out modiﬁca-
tion, provide novel insights into the mechanistic pathways of
disease14; however, the ability to evaluate the relationships
between OA severity and molecular biomarkers in mouse
models has been limited to analysis of serum or urine by
the small volume and inaccessibility of the SF in the syno-
vial joints of mice15. Concordantly, the primary obstacle*Address correspondence and reprint requests to: Dr Virginia
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1532preventing use of mouse SF in biomarker studies is the
lack of a repeatable method for harvesting and quantifying
the very small amounts of ﬂuid, estimated to be w1 mL, in
the murine knee joint.
In other animal models such as the canine meniscectomy
model of OA, joint lavage with saline has been used to re-
trieve the relatively large volumes of SF (50e200 mL)16e20,
and the dilution effect of the lavage has been corrected by
normalization to serum urea21; however, this method cannot
provide accurate SF retrieval of small volumes. Likewise, the
Whatman paper recovery (WPR) method has been used to
recover SF from joints with small SF volumes (w5 mL),
e.g., from guinea pig knees22, but the liquid, biomarker,
and cytokine recovery efﬁciencies of this method have not
previously been reported.
Thus, the aim of this study was to develop and validate
a method for recovery of small volumes of SF from mouse
joints. We investigated three means of SF recovery for their
applicability to mouse studies e WPR, polyacrylate bead
(PAB) recovery, and calcium sodium alginate compound
(CSAC) recovery. We hypothesized that either PAB or
CSAC recovery would provide a means of harvesting
a measurable volume of SF from the knee of a mouse in
a manner that allows quantitative analysis of biomarkers.
The measurements of total protein, COMP, and keratan
sulfate (KS) were explored.
1533Osteoarthritis and Cartilage Vol. 16, No. 12MethodsMEASURING SAMPLE VOLUMEThree methods of SF harvest were explored. Two methods (PAB and
CSAC described below) relied on accurate volume measurements with a pi-
pette, which we refer to here as the ‘pipette-dialing’ technique. The ‘pipette-
dialing’ technique is applicable to any standard Gilson micropipette sized
2 mL through 1000 mL. First, the pipette was set to 5 mL higher than the
approximate amount of sample. The sample of indeterminate size was cap-
tured using an appropriately sized low-retention micropipette tip (Genesee
Scientiﬁc Cat. No. 24-150RL). Caution was taken to ensure that the resultant
air pocket at the tip was clearly separated from the liquid. Finally, the
micropipette’s volume determination wheel was dialed-down until the sample
ﬁlled the very tip without any overﬂow. The value on the side of the pipette
was recorded as the volume of the sample.PAB ABSORBANCEPABs were the ﬁrst of three materials evaluated for their capability to
serve as a vehicle for small volume SF recovery. The ﬂuid absorption
capacity of poly(acrylic acid) partial sodium salt [SigmaeAldrich Cat. No.
436364], a lightly cross-linked PAB (PAB-L), was assessed by adding
1000 mL of deionized H2O to 10 lightly cross-linked PABs. The amount of
ﬂuid absorbed per bead was measured by recording DV (change in volume)
every 5 min using the pipette-dialing method on the unabsorbed liquid and
dividing this value by 10. This procedure was repeated three times.
Additionally, the effect of agitation on short-term liquid absorbance efﬁciency
was investigated by agitating samples with a titer plate shaker (Lab-Line
Industries, Model #4625; Melrose Park, IL) set on level 6 in between DV
measurements (six repetitions e three with agitation, three without). The
time a given sample spent on the shaker (ton shaker) was varied and plotted
against volumetric recovery.PAB RECOVERYDeionized H2O (1000 mL) was added to 10 PABs. The beads were then
allowed to absorb water for 15 min, at which point DV was recorded and
the excess water discarded. A 1000 mL of room temperature, saturated
NaCl solution was added, and DV was assessed at 5 min intervals. Measure-
ments ceased 90 min after the recovery liquid was added. Lastly, the optimal
time for recovery was identiﬁed by examining the data collected through
these repetitions. This protocol was performed three times.
The effect of preswelling PABs on SF recovery was determined by adding
3 mL of dH2O to each of three lightly cross-linked PABs. A total of 1 mL of
human knee waste SF was then added to each of the preswollen PABs as
well as three non-swollen PABs. Each bead was then placed in a separate
well of a 96-well polystyrene microplate. A total of 100 mL of saturated
NaCl solution was added to each well, and the entire plate was placed on
the shaker for 5 min at level 7. After agitation, DV was determined for each
group of beads. The recovered ﬂuid and an aliquot of the initial SF sample
(1:100 dilution in deionized H2O) were assayed for protein (BCA Protein,
Pierce, #23225).CSAC RECOVERYThe second of three materials evaluated for its capability to serve as a ve-
hicle for small volume SF recovery was Melgisorb (Tendra, Ref. 250600;
Go¨teborg, Sweden), a CSAC used as a dressing on wounds to absorb heavy
exudate. Small, circular pieces of the 2 inch 2 inch dressings were cut us-
ing a hole-punch with a 3/16 inch diameter. After absorbing the target liquid,
a total of 35 mL of alginate lyase in H2O (1 unit/mL concentrationx 55.04 g/
mL; derived from Flavobacterium, SigmaeAldrich, A1603-100MG) was
added, and the resultant mixture was vortexed brieﬂy and incubated at
34C for 30 min. Following this brief digestion period, 15 mL of 1.0 M Sodium
Citrate (C6H5Na3O7) was added to each sample to lower the viscosity of the
solution by chelating the alginate’s Ca2þ ions. The sample volume was then
recorded using the pipette-dialing method. For experiments in mouse knees,
small, circular pieces of 2 mm diameter were used satisfactorily in conjunc-
tion with the same procedure outlined above.WPR RELATED METHODSThe third and ﬁnal SF harvesting method to be evaluated involved What-
man paper (Whatman Cat. No. 3030 917) referred to here as the WPR
method. WPR was included as a reference method because it has been
used successfully to measure biomarkers in the w5 mL of SF estimated to
be present in guinea pig knee joints22. For determination of absorptive
capacity and recovery efﬁciency, large volumes (100 ml) were tested. A totalof 100 mL of 0.15 M saline was added to each piece of Whatman paper of 3/
16 inch diameter in a 1.8 mL tube and the samples were allowed to sit over-
night at 4C. The next morning the sample was centrifuged (13,000 rpm for
1 min) and the liquid was aspirated from each sample and frozen for later use.PROOF OF CONCEPT IN VITRO EXPERIMENTS WITH
HUMAN SFEach of the three SF harvest methods was optimized using small volumes
(1 ml) of human SF. Both total protein and KS recovery were assessed. PABs
were available in a range of cross-linked forms ranging from low to high. We
harvested SF with three levels of PAB cross-linkage: the previously men-
tioned PAB-L representing light cross-linkage; poly(acrylic acid) partial so-
dium salt-graft-poly(ethylene oxide) [SigmaeAldrich Cat. No. 432784-250G]
representing medium cross-linkage (PAB-M); and poly(2-hydroxyethylmetha-
crylate) (SigmaeAldrich Cat. No. 192066-1G) representing high cross-link-
age (PAB-H). Triplicate experiments were performed with each type of
PAB, preswollen with 3 mL of H2O before being used to collect 1 mL of SF.
During tests on human SF, Whatman paper pieces 3/16 inch in diameter
were cut with a hole-punch, and 1 mL of human knee SF was added to each.
The CSAC method was used to collect samples via the procedure outlined
above. An additional three samples were collected by CSAC, substituting
35 mL of 1.0 M Sodium Citrate for the speciﬁed 35 mL of alginate lyase.
Although it was necessary to add lyase during CSAC recovery in order to
ensure that the viscosity of the recovered sample was not prohibitive to DV
measurements, this latter set of CSAC samples was collected in order to in-
vestigate the effect of the lyase on the measurement of biochemical markers
(protein and KS). To summarize, the ﬁnal list of methodologies tested in trip-
licate for recovery of total protein and KS from human SF consisted of: PAB-L,
PAB-M, PAB-H, CSAC with lyase, CSAC without lyase, and WPR.PROOF OF CONCEPT EXPERIMENTS IN VIVO WITH MOUSE SFUpon animal sacriﬁce, SF was collected using CSAC from both knees of
12 adult male C57BL/6 mice, six of which had undergone left knee articular
fractures as has been previously described23. All of these mice were raised
on a high-fat (60%) diet. Each target joint was opened by suprapatellar ten-
donotomy within approximately 2 h of sacriﬁce, and the 2 mm piece of CSAC
was swabbed in each joint cavity. Following SF absorption (1e3 min), the
piece of CSAC was removed and placed in a Nunc tube. All CSAC samples
collected from mouse knees underwent lyase digestion within 4 h of initial SF
absorption. Some preliminary experiments using this procedure were done
with sentinel C57BL/6 mice to examine the feasibility of the CSAC recovery
method in a mouse model.PROTEIN, KS AND COMP ASSAYSTo correct for non-speciﬁc background potentially contributed by the vehi-
cles (WPR, PAB or CSAC), appropriate negative controls were always in-
cluded that consisted of the vehicle incubated with saline to control for
non-speciﬁc effects.BRADFORD PROTEIN ASSAYUnless otherwise stated, total protein levels were measured using the
Bradford Micro-Protein Determination. A total of 1 mL of each sample was
added to 99 mL of deionized H2O in respective wells of an optically clear, poly-
styrene 96-well microtiter plate. Bradford reagent was added at a 1:1 volumet-
ric ratio to each well, and, after 10 min, the optical absorbance at 595 nm was
recorded using a GENios Plate Reader (Tecan, A-5082, Austria).KS COMPETITIVE ENZYME-LINKED IMMUNOSORBENT
ASSAY (ELISA)KS levels were measured in all human SF samples using the monoclonal
antibody 5D4 (supplied by Dr Bruce Caterson, Cardiff, Wales) in a quantita-
tive inhibition ELISA24. SF samples were assayed at a ﬁnal dilution of 1:500.
Levels of 5D4-KS epitope were reported in terms of equivalents (expressed
in ng/mL) of a chondroitinase treated A1D1 preparation of bovine nasal car-
tilage. For purposes of conversion, a 1.0 ng protein sample of our aggrecan
standard is equivalent to 0.12 ng of puriﬁed KS-2 international standard (pro-
vided by Dr Eugene Thonar, Chicago, IL).COMP COMPETITIVE ELISACOMP was quantiﬁed by a competitive ELISA using monoclonal antibody
12C4 which recognizes an epitope of the carboxyl-terminal globular domain
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COMP. A total of 60 mL of 12C4 diluted 1:150,000 in Tris incubation buffer
containing 0.1% (wt/vol) BSA, 0.1% (wt/vol) Nonidet NP-40, 0.15 M NaCl,
and 10 mM TriseHCl pH 7.4 was added to 60 mL of diluted sample during
the primary binding step of the ELISA. On-plate dilution of samples was re-
covery-dependent, and ranged from 3:560 to 1:1020 in Tris IB. Otherwise,
the assay was performed as previously described26. A blank of each recov-
ery method was run on each applicable plate to account for potential back-
ground readings. Samples that were not detectable at tested concentration
levels due to background noise were assigned a stand-in value of one-half
of the lowest detectable sample concentration equal to 39.81 ng.STATISTICAL ANALYSESThe volumetric recovery data were found to be approximately normally
distributed via histogram-based analysis, and it also passed Levine’s test
for Homogeneity of Variance. Thus, Independent Samples t tests were
used to analyze those results. The data on effects of preswelling on protein
recovery had too few observations to be analyzed with a non-parametric
comparison between means, e.g., ManneWhitney U test, as such a test is
incapable of detecting signiﬁcance when the number of observations per
group is 3. Furthermore, since no compelling evidence suggested that
each methodology’s protein percent recovery population distribution would
be non-normal, the t test was the best tool available.
Analysis of variance (ANOVA) was not performed on total protein and KS
recovery data because the level of procedural differences between the
tested methodologies is not uniform. In other words, many method-speciﬁc
variables separate the three different classes (PAB, CSAC, WPR) of recov-
ery while only one class-speciﬁc variable (extent of cross-linkage or pres-
ence/absence of lyase) separated the particular instances within each
class. Modeling this degree of intricacy with ANOVA was impossible given
the small number of samples analyzed; therefore, ANOVA was only used
to compare the three types of tested PABs. This parametric analysis was
chosen because the data collected from these three methods passed
Levine’s test for Homogeneity of Variance. In the case of KS recovery, the
means of the three PAB methodologies were compared with the Kruskale
Wallace test. This non-parametric equivalent to ANOVA was used because
the KS percent recovery data for the three PAB methodologies failed
Levine’s test for Homogeneity of Variance.
Non-parametric comparisons for related (Wilcoxon Signed-Rank) and
unrelated (ManneWhitney U ) samples were used for comparisons between
knees of the same animals and between knees of different animals, respec-
tively. These data sets were small enough to discourage use of parametric
comparisons (n 30), but not small enough to negate the effectiveness of
the non-parametric equivalents; therefore, the two tests chosen were ideal
for our testing purposes.ResultsLIQUID ABSORPTION AND RECOVERYThe average ﬂuid absorption capacity of a single PAB-L
was found to be 24.3 mL of deionized H2O (dH2O) after
5 min, and a maximum of 35.5 mL after 90 min of unaided
absorption [Fig. 1(a)]. Introducing shaker plate agitation
increased the 5 min average liquid absorbance to 26.4 mL
[n¼ 10 per group; P¼ 0.029, Two-tailed Independent
Samples t test; Fig. 1(b)]. No formal absorption data were
collected on CSAC or WPR because each material was
able to quickly absorb over 10 mL of dH2O in 15 s under
empirical observation. PAB-L was used as our practical
paradigm for these initial measurements since they theoret-
ically absorb ﬂuid more quickly than PAB-M and PAB-H in
spite of the higher total absorptive capacity enjoyed by
the more highly cross-linked beads.
To optimize liquid recovery, the amount of deionized H2O
(dH2O) recovered using the PAB methodology with the
pipette-dialing technique method was plotted against
elapsed time [Fig. 1(c)]. In so doing, the recovery curve
was found to peak 5 min after the PABs were immersed in
saturated NaCl solution, at which point the average liquid re-
covered was 28.0 mL per bead [Fig. 1(c)]. To evaluate liquid
recovery efﬁciency of PAB-L, we attempted to recover 3 mL
of dH2O. The average recovery ratio (Vrecovered/Vabsorbed)
was 0.987 0.367 [mean standard deviation (SD)]obtained from 45 trials. This compared to an average recov-
ery ratio of 1.00 0.502 over 30 trials for CSAC.PROTEIN RECOVERY e HUMAN SFAn increase in protein recovery efﬁciency was observed
when preswelling each PAB-L with 3 mL of deionized H2O
[n¼ 3 per group; P¼ 0.004, Two-tailed Independent
Samples t test; Fig. 1(d)]; therefore, all three types of PAB
were preswollen during the subsequent inter-method
comparison of protein recovery. The six methodologies
(PAB-L, PAB-M, PAB-H, CSAC with lyase, CSAC without
lyase, and WPR) were tested for their ability to recover
protein from 1 mL of human SF [n¼ 3 per method,
Fig. 2(a)]. CSACwithout lyasewas themost unreliable of pro-
tein recovery methodologies. WPR was found to be more ef-
ﬁcient at protein recovery than CSAC with lyase (P¼ 0.002,
Two-tailed Independent Samples t test). Thedegree of cross-
linkage was found to be responsible for the rank-order
amongst the three PAB methods: PAB-L>PAB-M> PAB-
H (P¼ 0.011, One-Way ANOVA). This particular order was
expected because the long-term advantage in liquid absorp-
tivity of the beads with more cross-links was rendered moot
by the 5 min time limit imposed to mimic the constraints of
a manageable SF recovery procedure in mice.KS RECOVERY e HUMAN SFThe six methodologies were tested for their ability to
recover KS from human SF in order to evaluate each meth-
od’s ability to recover a biochemical marker more speciﬁc to
joint tissue. The efﬁciency of KS recovery was assessed
using the same human SF samples that were used in pro-
tein testing [n¼ 3 per method, Fig. 2(b)]. No difference
due to cross-linkage was detected between the three PAB
methodologies (P¼ 0.430, KruskaleWallace test). WPR
was found to be more efﬁcient than CSAC with lyase at
recovering KS (P¼ 0.015, Independent Samples t test).COMP RECOVERY e MOUSE SFCSAC was chosen for testing in mice due to: (1) its ability
to precisely and accurately quantify the volume of liquid
recovered, (2) a lower, non-speciﬁc background of CSAC
control in the 5D4 KS and 12C4 COMP ELISA assays com-
pared with PAB control (data not shown), and (3) the fact
that it was easier than polyacrylate to physically manipulate
in small joint spaces. To investigate proper dilution levels,
both ELISAs were run on SF samples collected with
CSAC from three C57BL/6 sentinel mice. Unfortunately,
the 5D4 ELISA was not able to detect any KS in these
samples, however, given that COMP was detectable with
the 12C4 ELISA in the CSAC-collected SF samples from
sentinel mice, the KS 5D4 assay was abandoned in favor
of further COMP testing.
In total, 12 C57BL/6 mice fed a high-fat diet (HFD) were
used for testing e six with articular fractures of the left
knee (HFD-fracture) and six without (HFD-non-fracture).
The overall average volume (meanSD) of SF recovered
from an individual joint with the CSAC method was
3.30 1.31 mL. More speciﬁcally, the mean volume recov-
ered from the left, fractured knees of the HFD-fracture
mice (3.78 0.93 mL) was higher than the mean volume
recovered from the right non-fractured knees of the same
animals (2.75 1.13 mL), and this difference approached
signiﬁcance (P¼ 0.079, ManneWhitney U test).
Fig. 1. Polyacrylate absorbance and recovery. (a, b) Mean volume of dH2O absorbed by a single PAB-L (n¼ 30) over time; (c) mean volume of
dH2O recovered from a single PAB (n¼ 30). (d) Preswelling PAB-L increased the amount of protein recovered, n¼ 3 per group (P¼ 0.004,
Independent Samples t test). Error bars represent a single SD.
1535Osteoarthritis and Cartilage Vol. 16, No. 12The mean COMP concentration of the fractured left
knees was higher than that of the contralateral non-
fractured right knees (3444 1515 ng/mL vs 2924
1302 ng/mL), and this difference too approached signiﬁ-
cance (P¼ 0.075, Wilcoxon Signed-Rank test). The mean
concentration ratio [(COMPleft knee)/(COMPright knee)] was
higher (P¼ 0.026, ManneWhitney U test) in the mice
subjected to articular fracture (52.1 62.2) when compared
to the non-fracture mice (0.89 0.76).
Total recovered COMP from each sample was assessed
by multiplying each computed concentration by the total
volume recovered from that knee (Table I). Mean total
COMP was higher in the fractured knees
(5676.2 2906.6 ng) than the non-fractured knees
(961.9 1153.4 ng) in the six fracture mice (P¼ 0.046, Wil-
coxon Signed-Rank test) (Fig. 3). Furthermore, the mean
total COMP ratio (jtotal left knee COMP (ng)j/jtotal right
knee COMP (ng)j) was higher (P¼ 0.004, ManneWhitney
U test) for the six fracture mice (55.6 58.2) compared to
their non-fracture counterparts (0.87 0.51) (Table I and
Fig. 3).Discussion
We tested three different materials for their utility as vehi-
cles for small volume SF harvest. We ﬁrst undertook pilot
studies with human SF followed by proof of concept exper-
iments in mouse knees. Based on the insights gleaned
through handling each of the three recovery vehicles(WPR, PAB, CSAC), CSAC with lyase clearly emerged as
the preferred method for recovering small volumes of SF.
We were able to quantify mouse knee SF COMP concen-
trations and SF total COMP, as well as calculate left/right
ratios of both measures. Overall, the total COMP left/right
ratio, best discriminated between fracture and non-fracture
knees (post/precomparison), showing the strongest statisti-
cally signiﬁcant difference between fracture and non-
fracture mice. The validity of total SF COMP depends on
the degree to which one can assume that all available
volume was recovered; however, this assumption appeared
to be reasonable in our experiments based on visual obser-
vations during the CSAC recovery procedure. Furthermore,
in addition to total COMP left/right ratio (that provided a con-
trol for biological variability between animals), the difference
between total COMP remained signiﬁcant in spite of the
small sample population (n¼ 12). This underscores the pri-
mary beneﬁt of the CSAC method, e.g., the ability to know
how much volume was recovered from each knee. Given
the results approaching signiﬁcance for the difference
between groups for absolute COMP concentration, a slightly
larger sample size would be needed for this measure to
overcome inter-animal variability. The promising results of
our mouse in vivo pilot study (using CSAC with lyase
method) supported our hypothesis that precise, quantitative
recovery of mouse SF was possible.
Although WPR was most efﬁcient for total protein and KS
recovery, the weights obtained from the available analytical
balance pre- and post-SF addition were too unreliable to be
of any use due to the light paper chads and limited SF
Fig. 2. Percent recovery comparison. (a, b) Comparisons between all six evaluated methodologies on percent recovery of total protein and KS,
respectively. WPR was more efﬁcient at protein recovery (a) and KS recovery (b) than CSAC with lyase (P¼ 0.002, P¼ 0.015, Independent
Samples t test). Error bars represent a single SD.
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ment via mass-subtraction. Thus, we found that the inability
to measure DV 3 mL with this method prevented accurate
biomarker measurements in samples collected from mouse
joints because biomarker concentrations could not be
calculated without knowing the volume of ﬂuid retrieved.Table










HFD-fracture 1 6268.81 39.81 157.47
2 8153.25 79.63 102.39
3 10235.61 2800.45 3.65
4 4768.83 476.23 10.01
5 2289.19 2335.52 0.98
6 2341.56 39.81 58.82
Mean 5676.21 961.91 55.55
HFD-non-fracture 7 721.80 10287.67 0.07
8 2598.94 1427.61 1.82
9 2793.16 3357.39 0.83
10 2710.52 2954.26 0.92
11 3236.96 4407.80 0.73
12 2507.48 2977.30 0.84
Mean 2428.14 4235.34 0.87
vol, Volume; L, left knee (fracture or sham fracture); R, right knee (conSimilarly, DV could not be measured reliably in CSAC
samples collected without the use of lyase due to the resul-
tant liquid’s viscosity. The high variances of the protein
recovery results for CSAC samples collected without lyase
suggested that biomarker measurement in such samples
would be inaccurate as well.I













5.0 5.0 1253.76 7.96 157.45
2.6 3.0 3135.87 26.54 118.14
3.0 2.4 3411.87 1166.85 2.92
3.3 2.6 1445.10 183.16 7.89
3.8 1.6 602.42 1459.70 0.41
5.0 2.2 468.31 18.10 25.88
3.78 2.8 1719.56 477.05 52.12
3.2 3.8 225.56 2707.28 0.08
2.0 2.6 1299.47 549.08 2.37
1.8 2.9 1551.76 1157.72 1.34
2.8 1.2 968.04 2461.89 0.39
5.1 3.1 634.70 1421.87 0.45
6.2 5.2 404.43 572.56 0.71
3.52 3.13 847.33 1478.40 0.89
trol).
Fig. 3. Mean SF COMP levels in mouse knees. Total COMP (left
panel) and COMP concentration (right panel) were highest in frac-
tured left knees compared with non-fractured right knees in HFD
fed mice. This difference in the fracture mice was statistically signif-
icant for total COMP (P¼ 0.046).
1537Osteoarthritis and Cartilage Vol. 16, No. 12Though PABs were found to exhibit potential for liquid
and biomarker recovery, further development of speciﬁc
iterations of the material are needed before it can be useful
for mouse SF recovery. For instance, in accordance with
the properties of the polyacrylate, the elastic capacity and
the elastic limit of PABs increase as cross-linkage
increases. Thus, the absorption/oscillation curve of more
extensively cross-linked PABs would likely be characterized
by a longer wave length and smaller slope due to the stron-
ger elastic inﬂuence on the system (Fig. 4); however, the
decrease in initial, short-term absorptivity is detrimental to
the use of PAB constructs with higher cross-linkage in
mouse SF recovery applications. Preswelling ameliorated
some of the negative effects of higher cross-linkage;
however, preswelling to a degree that the bead would still
ﬁt inside a mouse knee joint (w3 mL) was most helpful to
PAB-L in protein recovery applications. This is likely
because the added 3 mL represented a higher percentage
of the absorptive capacity of a PAB-L, producing a propor-
tionally greater increase in surface area. This increase in
surface area contributed to the relatively efﬁcient protein
recovery of PAB-L while also being the source of the
enhancement to the oscillation curve. Notably, it is likelyFig. 4. Effects of cross-linkage on PAB properties. Varying levels of
cross-linkage and their theoretically approximated effects on the
absorption/oscillation curve of a PAB.that a PAB created especially for SF recovery could bypass
these discussed limitations. Without such a specially
constructed polyacrylate though, CSAC stands alone as
the material of choice for small volume SF recovery.
To date, COMP in serum and SF has been repeatedly
validated as a marker of cartilage turnover that correlates
with OA progression in human27,28 and guinea pig12,29
systems, as well as with OA progression and therapeutic
response in canine systems19,30. Serum COMP has been
one of the few markers that has been evaluated in a mouse
model of OA31; however, this study represents the ﬁrst
known SF biomarker analyses in a mouse model system,
namely for SF COMP. Being able to measure COMP levels
in mouse SF provides a promising window into OA pathol-
ogy due to the relatively inexpensive, reproducible, and
time efﬁcient nature of mouse models of OA. Although
mice are reported to have detectable levels of KSI (KS N-
linked to Asn residues in the core protein; typically found
in the cornea)32, and mouse aggrecan has putative KSII
binding sites33,34, KSII was not detectable in mouse SF
using the 5D4 ELISA.
In summary, the CSAC methodology utilizing lyase
unquestionably emerged as the optimal protocol for SF
recovery from mice. Given the elevations of SF COMP
detected in the mouse knee fracture group of this study
using a relatively small number of animals, CSAC recovery
of mouse SF is clearly feasible, reliable, and able to provide
valuable information indicative of metabolic turnover in the
joint. We believe some troubleshooting would need to be
done to evaluate the optimal processing for each analyte
one would want to measure, but with the appropriate optimi-
zation, this method could prove very useful to the ﬁeld as an
adjunctive measure to complement histological evaluation
of mouse models of arthritis.
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